bpc-157 human clinical trials status fda approval Status: Is It Approved for Use? BPC-157 Benefits: Gut, Joints, Muscle,
Description
Exopolysaccharides produced by Streptococcus mutans glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms
doi: 10.1111/j.1365-2265.1995.tb02929.x 103 RaunKHansenBSJohansenNLThogersenHMadsenKAnkersenMet al
or 200 mg/kg b.w., s.c., in pre-(24 hours or 1 hour before alloxan application), co- and post- (48 hours following alloxan application) treatments
Not approved by the TGA or FDA for human consumption, therapeutic use, or cosmetic application
